Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q3 2014 · 10-Q
Revenue$518.00K$518.00K−67.9% vs Q3 2013 Net Income-$9.39M-$9.39MN/M vs Q3 2013 EPS Diluted-$0.12-$0.12N/M vs Q3 2013 Gross Profit$181,000−73.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$7,237,000N/M Free Cash Flowderived-$7,562,000N/M Margins · derivedGross margin34.9%−7.4 pt vs Q3 2013
Operating margin-1523.2%−999.6 pt vs Q3 2013
Net margin-1811.8%−1486.4 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 7, 2014 · 38 d after period end